Eisai: New Data on LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus Sunitinib
In First-Line Treatment for Patients With Advanced Renal Cell Carcinoma From Pivotal Phase 3 CLEAR/KEYNOTE-581 Trial Presented at 2021 ASCO
Read More
Eisai
Eisai Establishes Pharma Sales Subsidiary in Vietnam
Eisai Co. Ltd has established a new pharmaceutical sales subsidiary in Ho Chi Minh City, the Socialist Republic of Viet
Read More
Eisai to Launch Sahne Medical Spray and Sahne Medical Cream
JCN Newswire Eisai Co., Ltd. announced today that it has launched Sahne Medical Spray and Sahne Medical Cream (both are
Read MoreEisai to Present Latest Data of Lemborexant at 34th Annual Sleep Meeting (SLEEP2020)
JCN Newswire Eisai Co., Ltd. announced today that a total of 10 presentations including the latest data on its in-house
Read MoreEisai to Present Latest Data on Pipeline Assets in the Area of Alzheimer’s Disease and Dementia at the Alzheimer’s Association International Conference (AAIC) 2020
TOKYO, July 22, 2020 – (JCN Newswire) – Eisai Co., Ltd. announced today that the company will conduct a total
Read MoreEisai: Smartphone App for Vital Signs Measurement of Patients With the Novel Coronavirus Infection Experimental Study Project Adopted as AMED Project
Preventing medical infrastructure collapse by a monitoring system linked to LINE TOKYO, July 20, 2020 – (JCN Newswire) – Allm
Read More